Clinical Trial Update: Efficacy Study of Ilaprazole to Treat Erosive Esophgitis [Phase 3]

View source ↗

Summary

Phase 3 efficacy study of ilaprazole for erosive esophagitis and GERD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Erosive Esophagitis, GERD | Phase 3 | Status: COMPLETED